These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34544689)

  • 1. Safety and efficacy of low-dose diazoxide in small-for-gestational-age infants with hyperinsulinaemic hypoglycaemia.
    Chandran S; R PR; Mei Chien C; Saffari SE; Rajadurai VS; Yap F
    Arch Dis Child Fetal Neonatal Ed; 2022 Jul; 107(4):359-363. PubMed ID: 34544689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Watchful waiting versus pharmacological management of small-for-gestational-age infants with hyperinsulinemic hypoglycemia.
    Chandran S; Jaya-Bodestyne SL; Rajadurai VS; Saffari SE; Chua MC; Yap F
    Front Endocrinol (Lausanne); 2023; 14():1163591. PubMed ID: 37435482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case report: A novel
    Chandran S; Verma D; Rajadurai VS; Yap F
    Front Endocrinol (Lausanne); 2024; 15():1471596. PubMed ID: 39421536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised controlled trial of diazoxide for small for gestational age neonates with hyperinsulinaemic hypoglycaemia provided early hypoglycaemic control without adverse effects.
    Balachandran B; Mukhopadhyay K; Sachdeva N; Walia R; Attri SV
    Acta Paediatr; 2018 Jun; 107(6):990-995. PubMed ID: 29385640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose diazoxide is safe and effective in infants with transient hyperinsulinism.
    Malhotra N; Yau D; Cunjamalay A; Gunasekara B; S A; Gilbert C; Morgan K; Dattani M; Dastamani A
    Clin Endocrinol (Oxf); 2024 Feb; 100(2):132-137. PubMed ID: 38059644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and molecular characterisation of hyperinsulinaemic hypoglycaemia in infants born small-for-gestational age.
    Arya VB; Flanagan SE; Kumaran A; Shield JP; Ellard S; Hussain K; Kapoor RR
    Arch Dis Child Fetal Neonatal Ed; 2013 Jul; 98(4):F356-8. PubMed ID: 23362136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diazoxide-induced pulmonary hypertension in hyperinsulinaemic hypoglycaemia: Recommendations from a multicentre study in the United Kingdom.
    Chen SC; Dastamani A; Pintus D; Yau D; Aftab S; Bath L; Swinburne C; Hunter L; Giardini A; Christov G; Senniappan S; Banerjee I; Shaikh MG; Shah P
    Clin Endocrinol (Oxf); 2019 Dec; 91(6):770-775. PubMed ID: 31520536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paradoxical hypoglycaemia associated with diazoxide therapy for hyperinsulinaemic hypoglycaemia.
    Ponmani C; Gannon H; Hussain K; Senniappan S
    Horm Res Paediatr; 2013; 80(2):129-33. PubMed ID: 23886961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Adverse Events in Children With Congenital Hyperinsulinism Treated With Diazoxide.
    Herrera A; Vajravelu ME; Givler S; Mitteer L; Avitabile CM; Lord K; De León DD
    J Clin Endocrinol Metab; 2018 Dec; 103(12):4365-4372. PubMed ID: 30247666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience of Octreotide Therapy for Hyperinsulinemic Hypoglycemia in Neonates Born Small for Gestational Age: A Case Series.
    Pan S; Zhang M; Li Y
    Horm Res Paediatr; 2015; 84(6):383-7. PubMed ID: 26448570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When is it best to discontinue diazoxide in children with persistent hyperinsulinaemic hypoglycaemia and negative genetics for K
    Güemes M; Kostopoulou E; AlYahyaei M; Gilbert C; Shah P
    Clin Endocrinol (Oxf); 2022 Feb; 96(2):107-113. PubMed ID: 34370339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed presentation of prolonged hyperinsulinaemic hypoglycaemia in a preterm small-for-gestational age neonate.
    Chong JH; Chandran S; Agarwal P; Rajadurai VS
    BMJ Case Rep; 2013 Dec; 2013():. PubMed ID: 24351577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterozygous Insulin Receptor
    Sethi A; Foulds N; Ehtisham S; Ahmed SH; Houghton J; Colclough K; Didi M; Flanagan SE; Senniappan S
    J Clin Res Pediatr Endocrinol; 2020 Nov; 12(4):420-426. PubMed ID: 31989990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syndromic Forms of Hyperinsulinaemic Hypoglycaemia-A 15-year follow-up Study.
    Kostopoulou E; Dastamani A; Güemes M; Clement E; Caiulo S; Shanmugananda P; Dattani M; Gilbert C; Hurst JA; Shah P
    Clin Endocrinol (Oxf); 2021 Mar; 94(3):399-412. PubMed ID: 33345357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exceptional diazoxide sensitivity in hyperinsulinaemic hypoglycaemia due to a novel HNF4A mutation.
    Arya VB; Kalitsi J; Hickey A; Flanagan SE; Kapoor RR
    Endocrinol Diabetes Metab Case Rep; 2019 May; 2019():. PubMed ID: 31096182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diazoxide-mediated insulin suppression in obese men: a dose-response study.
    Schreuder T; Karreman M; Rennings A; Ruinemans-Koerts J; Jansen M; de Boer H
    Diabetes Obes Metab; 2005 May; 7(3):239-45. PubMed ID: 15811140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term treatment of persistent hyperinsulinaemic hypoglycaemia of infancy with diazoxide: a retrospective review of 77 cases and analysis of efficacy-predicting criteria.
    Touati G; Poggi-Travert F; Ogier de Baulny H; Rahier J; Brunelle F; Nihoul-Fekete C; Czernichow P; Saudubray JM
    Eur J Pediatr; 1998 Aug; 157(8):628-33. PubMed ID: 9727845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-Dose, Diazoxide-Mediated Insulin Suppression Boosts Weight Loss Induced by Lifestyle Intervention.
    Loves S; van Groningen L; Filius M; Mekking M; Brandon T; Tack CJ; Hermus A; de Boer H
    J Clin Endocrinol Metab; 2018 Nov; 103(11):4014-4022. PubMed ID: 30202851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sirolimus in infants with congenital hyperinsulinism (CHI) - a single-centre experience.
    Panigrahy N; Chirla DK; Bagga N; Gunda RK; Sukhija B; Reddy L
    Eur J Pediatr; 2022 Jan; 181(1):407-412. PubMed ID: 34304300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sirolimus therapy in a child with partially diazoxide-responsive hyperinsulinaemic hypoglycaemia.
    Loke KY; Anjian AS; Yijuan YL; Ho Wei Li C; Güemes M; Hussain K
    Endocrinol Diabetes Metab Case Rep; 2016; 2016():. PubMed ID: 27855235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.